Investigation Overview
February 9, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Ocera Therapeutics Inc (NASDAQ:OCRX) shares over potential securities laws violations by Ocera Therapeutics and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the ...
You must register (for free) or login to view the entire investigation.